Skip to main content
BMJ Global Health logoLink to BMJ Global Health
. 2017 Apr 26;2(2):e000211. doi: 10.1136/bmjgh-2016-000211

Developing an expanded vector control toolbox for malaria elimination

Gerry F Killeen 1,2, Allison Tatarsky 3, Abdoulaye Diabate 4, Carlos J Chaccour 5,6, John M Marshall 7, Fredros O Okumu 1,8, Shannon Brunner 3, Gretchen Newby 3, Yasmin A Williams 3, David Malone 9, Lucy S Tusting 10, Roland D Gosling 3
PMCID: PMC5444090  PMID: 28589022

Abstract

Vector control using long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) accounts for most of the malaria burden reductions achieved recently in low and middle-income countries (LMICs). LLINs and IRS are highly effective, but are insufficient to eliminate malaria transmission in many settings because of operational constraints, growing resistance to available insecticides and mosquitoes that behaviourally avoid contact with these interventions. However, a number of substantive opportunities now exist for rapidly developing and implementing more diverse, effective and sustainable malaria vector control strategies for LMICs. For example, mosquito control in high-income countries is predominantly achieved with a combination of mosquito-proofed housing and environmental management, supplemented with large-scale insecticide applications to larval habitats and outdoor spaces that kill off vector populations en masse, but all these interventions remain underused in LMICs. Programmatic development and evaluation of decentralised, locally managed systems for delivering these proactive mosquito population abatement practices in LMICs could therefore enable broader scale-up. Furthermore, a diverse range of emerging or repurposed technologies are becoming available for targeting mosquitoes when they enter houses, feed outdoors, attack livestock, feed on sugar or aggregate into mating swarms. Global policy must now be realigned to mobilise the political and financial support necessary to exploit these opportunities over the decade ahead, so that national malaria control and elimination programmes can access a much broader, more effective set of vector control interventions.


Key questions.

What is already known about this topic?

  • Vector control in low and middle-income countries (LMICs), using long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS), accounts for most of the unprecedented malaria burden reductions achieved in the 21st century.

  • LLINs and IRS are highly effective in LMICs, but are insufficient to eliminate malaria transmission in many settings because of operational constraints, mosquitoes that behaviourally avoid contact with them inside houses and growing resistance to available insecticides.

  • However, mosquito control in high-income countries (HICs) is predominantly achieved with a combination of long-standing high coverage with mosquito-proofed housing and environmental management, supplemented with proactive, large-scale insecticide applications to larval habitats and outdoor spaces that kill off vector populations en masse.

  • In contrast with the prescriptive, centralised global recommendation of LLINs and IRS as ubiquitous first-choice vector control tools for LMICs, the more aggressive, area-wide population suppression practices of HICs are idiosyncratically tailored to local conditions by decentralised mosquito abatement programmes, which are governed, funded and managed at the local level.

What are the new findings?

  • A number of existing technologies are available that remain underdeveloped or underexploited, which could be rapidly mobilised to enable implementation of far more diverse, effective and sustainable malaria vector control strategies in LMICs.

  • Where sufficient implementation capacity exists, and human population density is high enough to make the cost per person protected affordable, systems for vertical, proactive, locally managed delivery of mosquito population abatement technologies already used extensively in HICs should be developed and evaluated in LMICs. Experiences from programmes in HICs may be selectively leveraged wherever appropriate in LMIC contexts.

  • Furthermore, a diverse range of repurposed and emerging technologies for targeting mosquitoes when they enter houses, feed outdoors, attack livestock, feed on sugar or aggregate into mating swarms are becoming available. These new technological options could all be developed into programmatically scalable vector control tools within the decade ahead and provide unprecedented opportunities for more effective suppression of malaria transmission in LMICs. Many of these technologies could be delivered horizontally, making them practically applicable even in settings with weak implementation capacity.

Recommendations for policy

  • Global policy must now fully and consistently realign with both the programmatic needs and biological realities of malaria vector control, to prioritise accelerated development of these diverse options for malaria vector control in LMICs.

  • Developing such an expanded toolbox for malaria vector control will require investment in product and system development, high-quality evaluations of efficacy and effectiveness, and operational research to define best practices for programmatic use of these additional interventions.

Introduction

Vector control with long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) accounts for an estimated 78% of the 663 million malaria cases averted globally since 2000.1 Despite these achievements, over 214 million malaria cases and 438 000 malaria-attributable deaths occurred in 2014.2 There are renewed calls for malaria eradication by 2040 and new bold global targets for malaria elimination: elimination from four southern African countries by 2020, a malaria-free Asia-Pacific by 2030,3 reductions in malaria incidence by 90% globally, and elimination in 35 countries by 2030.4 While IRS and LLINs provide the backbone of malaria control and elimination efforts in low-income and middle countries (LMICs) today, more aggressive approaches to vector control will be needed to achieve these ambitious future goals.5 6 In countries that have successfully eliminated malaria, including high-income countries (HICs) such as the USA and Australia,7 8 as well as lower income countries such as Mauritius, Sri Lanka and Turkey, mosquito populations were suppressed using more integrated vector control models, including multiple measures attacking different stages of the mosquito life cycle.9–11 To accelerate progress towards elimination, it is critical to revisit these existing methods, and to add new and emerging technologies that target different mosquito behaviours and life stages, so that low-income malaria-endemic countries can avail of a much larger arsenal of effective vector control options.

LLINs and IRS have been highly effective interventions in LMICs,1 but they have fundamental limitations, including (1) their vulnerability to selection for insecticide resistance,12 13 (2) their reliance on population-wide human compliance for operational effectiveness,14 15 (3) considerable cost,2 16–18 and (4) important biological constraints to their efficacy caused by mosquitoes that feed on humans and/or animals outdoors, rest outdoors, or enter houses but then rapidly exit from them without being exposed to insecticides.5 6 19

Resistance to all four classes of insecticide available for public health, especially the pyrethroids we rely on for LLINs, is now prevalent across Africa.12 13 New chemical insecticides are expected to enter the market over the next few years, but these may be similarly vulnerable to selection for physiological resistance if used as single active ingredients.12 13 Improved deployment formats are needed to target insecticides more efficiently,20–22 so that mosaics, rotations or combinations,23 possibly including biological agents,24 can be affordably applied. For now, IRS is the only recommended alternative to LLINS for applying insecticides within houses, and most available alternatives to pyrethroids are far more expensive, resulting in slow uptake16 and contraction of IRS coverage wherever they have been adopted.17 As a result of all these financial and practical limitations, only 31% of African households have sufficient LLINs25 and global IRS coverage has shrunk to only 3.4% of the world's at-risk population.2

The impacts of LLINs and IRS are also biologically limited by their reliance on strong vector behavioural preferences for resting or biting in houses, usually associated with frequent feeding on humans.5 6 19 Wherever vectors exist that feed on animals, rest and/or feed outdoors, or can enter houses but rapidly exit again, malaria transmission is likely to persist despite a scale-up of LLINs and IRS, a phenomenon referred to as residual transmission (figure 1). In areas with self-sustaining levels of residual transmission, elimination of malaria cannot be achieved with LLINs and/or IRS alone, even if applied at universal coverage against a fully insecticide-susceptible vector population.5 6 19 26 Reducing malaria transmission to levels where the rate of reinfection is low enough to eliminate parasite reservoirs from humans will require improved protection against human-biting mosquitoes, as well as more broadly effective population control of all major vector species, regardless of their diverse behavioural traits.5 6 19

Figure 1.

Figure 1

Schematic illustration of malaria vector mosquito life histories, highlighting the most important behaviours that mediate residual transmission of malaria despite high coverage with long-lasting insecticidal nets and indoor residual spraying,5 19 as well as the many intervention opportunities that remain to be exploited with existing or emerging vector control methods. This figure has been updated relative to a previous version,5 to reflect evidence for the inclusion of additional intervention options, specifically odour-baited traps and targets for killing host-seeking mosquitoes (box 2), as well as targeted space spraying of mosquitoes (box 1), especially when they aggregate into mating swarms (box 3).

In this analysis, we outline immediate opportunities for developing and implementing more aggressive malaria vector control strategies in LMICs, by leveraging transferable programmatic experiences from HICs with existing technologies, as well as exploiting repurposed and emerging new technologies. Additional new technologies include autodissemination of larvicides,27 genetic control,28 biological control29 and endectocides (systemic insecticides that are delivered to the tissues of target animals through oral, injectable or implant formulations) for humans,30 31 but these are unlikely to be ready for programmatic assessment19 in <10 years. Here, we focus selectively on lower hanging fruit that could be feasibly deployed at scale by national malaria control programmes within the decade immediately ahead.

Institutionalising robust delivery systems for existing mosquito population suppression technologies

Mosquito control in HICs has been predominantly achieved through a combination of mosquito-proofed housing and environmental management, supplemented with frequent, large-scale insecticide applications to larval habitats and outdoor spaces, to kill off vector populations en masse.7 8 32 33 Some caution is required when considering the success of these HIC mosquito abatement programmes, because they have been conducted in less challenging temperate climates, where less efficient vectors bite humans too infrequently to mediate intense malaria transmission.6 Also, many of their routine operational practices will not be directly transferable to more financially constrained LMIC contexts, the needs of which are epidemiologically and ecologically diverse. Nevertheless, these interventions have been so successful that their malaria elimination function is often taken for granted, and many of the technologies or experiences may be relevant to malaria control and elimination in LMICs.

Many well-established and highly effective mosquito control technologies that have been applied in HICs for decades7 8 remain to be widely adopted in LMICs because the necessary delivery systems and guidance have yet to be developed.5 Most HIC mosquito control programmes predominantly rely on large-scale larval source management (LSM) interventions to prevent the emergence of adult mosquitoes, complemented by space spraying of insecticides to tackle adult vector mosquitoes that do emerge (box 1, figure 1). Delivery of such proactive vector population control approaches typically requires vertical but decentralised delivery systems, managed locally by technical specialists, such as vector biologists, engineers and planners.7 8 While HIC mosquito control programmes are predominantly staffed by such advanced specialists, such cadres are much sparser in LMICs, so the institutional structures and operational processes must be tailored accordingly.9 34 Encouragingly, several examples of active, surveillance-based, vertically delivered local mosquito control programmes do exist in LMICs,11 operating at costs that are comparable with universal coverage of LLINs and IRS.35–37 Across settings, key features contributing to effective mosquito control systems include strong governance, dedicated financing, and decentralised management, robust entomological surveillance, and adaptive design of locally tailored intervention packages.

Box 1. Existing vertically delivered mass population suppression technologies that have been underexploited in low-income and middle-income countries (LMICs).

  • Larval source management (LSM) to prevent emergence of adult mosquitoes: The mainstay of most mosquito control programmes in high-income countries (HICs) is aggressive control of immature mosquitoes in aquatic habitats through LSM, which includes all forms of environmental management, biological control and/or regular larvicide application that prevent immature aquatic stages of mosquitoes from emerging as adults.9 10 The WHO currently recommends larviciding as a supplement to long-lasting insecticidal nets and indoor residual spraying in LMICs where larval habitats are few, fixed and findable, a situation for which supporting evidence of success in LMICs already exists.9 10 However, given the advances in application technologies (eg, improved aerial and hand application systems) and emerging technologies for remotely identifying larval habitats, both driven by HIC markets over recent decades, LSM interventions may now become feasible in many LMIC contexts where it would previously have been considered unrealistic or unaffordable.

  • Space spraying to kill flying and resting adult mosquitoes: Ground or aerial delivery of insecticides in the form of fine sprays, with small droplet sizes that remain suspended in the air for long periods, can kill mosquitoes which are resting or flying in the targeted time and place.47 This practice is often referred to as space spraying or fogging, and is a mainstay of HIC mosquito control programmes as a response to disease outbreaks and/or increase in mosquito abundance.7 8 However, it has also been used in some LMIC settings, including countries like Turkey, Mauritius and Sri Lanka that have recently achieved malaria elimination.11 In its first elimination attempt, Haiti used aerial space spray to control Anopheles populations and reduce malaria transmission, and ground-based space spraying has been employed successfully for malaria vector control in India, Tanzania and El Salvador.47–49

The LSM and space-spraying interventions these programmes rely on are both area-wide interventions, so their application costs depend on the size of the catchment to be treated. Thus, the denser the human population, the more cost-efficient these measures become per person protected. With ongoing population growth, urbanisation and democratisation, development of such vertical but decentralised mosquito control programmes becomes an increasingly viable solution for many LMICs. Even now, ∼25% of the world's at-risk population already lives at densities of at least 1000 people per square kilometre, matching the sparsest population density at which LSM has already proven efficacious in Africa, albeit in the form of a district-scale research project rather than a larger programmatic evaluation.38

Adapting and repurposing existing technologies to target vulnerable behaviours of adult mosquitoes

The remaining 75% of the world's malaria-prone population is probably too sparsely distributed to support specialist vertical programmes for active mosquito abatement. Therefore, other technological solutions requiring less advanced delivery capacity will also be needed.

Fortunately, a number of existing technologies are available for targeting adult mosquito blood-feeding behaviours, which could be readily adapted or repurposed for malaria vector control, and conveniently delivered through existing, non-specialist, horizontal distribution systems in LMICs (box 2, figure 1). While IRS and LLINs have been used to great effect1 2 as affordable approaches to protecting sleeping and living spaces, they should ultimately be superseded by mosquito-proofed housing. However, considerable fractions of malaria transmission occur outdoors5 or within open housing designs that lack solid walls, much less a door. Insecticide-treated clothing or emanators for vapour-phase insecticides will therefore be needed to extend protection into the outdoor environment. Also, veterinary insecticides or mosquito traps baited with synthetic host odours may be used to achieve population suppression of outdoor-biting mosquito species. Indeed, such mass population abatement will most likely be essential to eliminate and prevent the reintroduction of malaria anywhere that vectors feed often enough on humans to mediate intense residual malaria transmission but also often enough on animals to evade population control with human-targeted interventions alone.6

Box 2. Broadening horizontally delivered options for targeting blood-seeking adult mosquitoes.

  • Improving and extending physical protection of houses and peridomestic spaces:50 Permanent housing modifications, such as window screening, sealed eaves and closed ceilings, can elicit remarkably high user acceptability, uptake and willingness to pay.51 Furthermore, mobile mosquito-proofed shelters may extend this approach to migrant lifestyles.52 In settings where long-lasting insecticidal nets (LLINs) and/or indoor residual spraying (IRS) previously performed mosquito population suppression functions,6 insecticide treatments for such screening materials are readily available.53 54 Furthermore, some remarkably simple modifications to houses can turn them into lethal mosquito traps with20–22 or without55 insecticide. Critically, even these new formats that do require insecticide need far less active ingredient per household continuously protected,20–22 so implementation of the Global Plan for Insecticide Resistance Management23 may actually become affordable in practice.

  • Extending coverage with solid-phase contact insecticides by treating clothing: Treating even the most basic garments and bed clothes with contact insecticides has long been known to protect against malaria exposure indoors and outdoors.56 57 However, this approach can be limited by incomplete body coverage of many clothing practices in tropical climates, as well as restriction to a single pyrethroid insecticide (permethrin) which is safe enough for direct skin contact. While it might be possible to address the former limitation by supplementing with topical repellents applied to exposed skin,58 these only provide short-lived protection and require frequent reapplications, so they may be too expensive and impractical for effective, continuous, indefinite use in many low-income and middle-income country (LMIC) contexts.59 Furthermore, their active ingredients are often actually irritants rather than repellents in the strict sense,60 so they can exacerbate existing inequities by diverting mosquitoes to feed on unprotected non-users nearby61 62 and undermine the impact of existing lethal interventions.41 63

  • Vapour-phase insecticides for protecting open spaces: Devices which emanate vapour from volatile insecticides or repellents into the air are already widely used in HICs for protection of open spaces where people are usually awake and active.64 65 Encouragingly, one of the most widely used of these existing vapour-phase insecticides has recently been reformulated into low-technology emanator formats that provide protection lasting several months, at costs that should be affordable even in LMICs.66–68 While transfluthrin, and several similarly volatile pyrethroids, are often described as spatial repellents,60 69 they can actually incapacitate65 or even kill mosquitoes.70 They are therefore described here as vapour-phase insecticides, to distinguish them from repellents and irritants in the strict sense, which may be associated with considerable limitations, disadvantages and risks.41 61–63

  • Odour-baited traps targeting host-seeking mosquitoes: Recent large-scale epidemiological trials have conclusively demonstrated mass suppression of the notoriously efficient African vector Anopheles funestus, and dramatically reduced malaria transmission by this widely distributed mosquito.71 These solar-powered traps are entirely self-sufficient in terms of electrical power and also provide sufficient surplus to provide household lighting and charge mobile phones. Given these direct benefits at the household level, irrespective of the impact on mosquitoes or malaria transmission, it may therefore be possible to distribute such traps programmatically through horizontal delivery mechanisms. Efficacy against a wider diversity of vector species will, however, require the development of affordable sources of carbon dioxide, or low-bulk substitutes for it.72

  • Veterinary insecticides to target vectors feeding on livestock: Most malaria vector species prefer animals over humans5 6 and are particularly dependent on cattle as a source of blood.73 A diverse range of advanced veterinary insecticide products exist for treating livestock animals, many of which could be readily repurposed for population suppression of malaria vectors through existing LMIC agricultural extension and market subsidy systems.44 74 Targeting insecticide treatments to livestock can achieve the same kind of population suppression of mosquitoes which usually feed on animals,75 in the same way that LLINs and IRS do15 for human-specialised vectors.6 41 76 A particularly attractive aspect of targeting malaria vectors when they attack livestock is that there are already strong markets, subsidies, delivery systems and market intervention experience with these products in LMICS.77

Beyond the well-understood blood-feeding behaviours that are most obvious as targets for mosquito control, other behaviours that are critical to mosquito survival can be targets for malaria vector control (figure 1 and box 3). While female mosquitoes need blood from animals to develop their eggs to maturity, they also feed on plant sugar sources to maintain their energetic requirements. Male mosquitoes also feed on sugar, so both sexes can be targeted with attractive toxic sugar baits to deplete local vector populations. Aggregation of male mosquitoes into swarms, to attract and compete for female mosquitoes, presents another critical mosquito behaviour that may be targeted with ground-based insecticide sprays.39

Box 3. Emerging opportunities for targeting adult mosquitoes when they seek sugar or mates.

  • Attractive toxic sugar baits (ATSBs): All mosquito species exploit sugar as a source of adult nutrition, so existing ATSB products designed for other insects may be highly effective for population control of malaria vectors. Additionally, home-made prototypes, constructed in situ with materials that are readily available in most African villages, have performed remarkably well against malaria vector populations in the few small-scale trails completed until now.5 78 While some concerns with respect to impacts on non-target organisms persist, formulations using only environmentally friendly natural products are now becoming available.79 80

  • Targeted space spraying of mating swarms: Male mosquitoes aggregate in swarms, where they compete for the attention of female mosquitoes visiting them in search of a mate, usually for an hour or less at dusk or dawn. Mating swarms have been documented for several important malaria vector species all across Africa.81 One of the considerable advantages of spraying mating swarms is that they occur during specific, predictable, limited time periods, at dawn and/or dusk, at repeatedly reused locations that can be mapped.81 Preliminary, village-scale trials of manually targeting these aggregations with hand-held insecticide aerosol spray cans in Burkina Faso have yielded impressive early results,39 suggesting an exciting potential LMIC malaria control application for the well-established ground-based space-spraying technologies used so widely in HIC mosquito control programmes.

While sugar-feeding and mating behaviours are attractive targets for developing new vector control strategies (box 3), these behaviours do not directly mediate malaria transmission so they have received little research attention and remain poorly understood.40 The full potential for epidemiological impact and optimal delivery practices for these strategies remains unclear. Strategic investment is needed to develop these intervention strategies, as well as the supporting knowledge base regarding the fundamental biology of malaria vector mosquitoes.40

Programmatic, evidence-based development of new vector control strategies

A range of existing products and promising prototypes are now available that could be rapidly adapted for malaria vector control in LMICs (boxes 2 and 3). After decades of reliance on prescriptive ‘one size fits all’ global policies and pessimism about what is feasible in LMICs, the time has now come to begin developing the full diversity of available intervention opportunities. So how will countries adopt new strategies and technologies in the absence of definitive epidemiological evidence of efficacy, including rigorously controlled phase III efficacy trials? Fortunately, the historical evidence base (box 4), and now the WHO policy,19 are both firmly supportive of a ‘learning-by-doing’ strategy, rather than waiting for the evidence base to catch up with programmatic needs. With the exception of the recent LLIN scale-up, the most successful vector control programmes in history, including IRS and LSM for malaria prevention, were established and developed through programmatic phase IV monitoring, evaluation and operational research, without any preceding phase III trials (box 4). Such programmatic evaluations should begin at modest pilot scales, with rigorous epidemiological and entomological evaluation, as well as embedded operational research, followed by a progressive, rational roll-out as the necessary technologies, systems and supporting evidence mature.5 19

Box 4. Examples of successful large-scale vector control programmes developed through ‘learning-by-doing’ strategies, following direct transition to phase IV effectiveness evaluations without any intermediate phase III efficacy studies.

Against malaria vectors specifically:

  • Numerous larval source management (LSM) programmes in the first half of the 20th century, including several successes in tropical of Africa, Asia and Latin America.9 10

  • Indoor residual spraying (IRS) against malaria vectors as the primary vector control measure of the Global Malaria Eradication Program in the second half of the 20th century, which enabled elimination of malaria from dozens of previously endemic countries.82

  • Largely spontaneous and horizontal uptake of mosquito-proofed housing to protect many populations of the world during the first half of the 20th century, including expatriates living in what we now call low-income and middle-income countries (LMICs), canal workers in Panama and residents of southern USA.32 33

  • The systematic, vertical, proactive and decentralised local mosquito population abatement programmes established in high-income countries, especially the USA and Australia,7 8 and to a far lesser extent in LMICs,9–11 over the past half century.

Against vectors of other pathogens:

  • The Onchocerciasis Control Program spanning 10 west African countries in the latter quarter of the 20th century, which relied primarily on LSM of blackflies in rivers.83

  • Southern Cone Initiative to eliminate American trypanosomiasis through IRS against triatomine bugs living inside houses.84

  • Several large-scale, vertical Tsetse control programmes scattered across Africa, deploying varying combinations of attractive traps and targets with area-wide, outdoor space and surface spraying.85

Importantly, none of these exciting new vector control interventions will provide a universally applicable panacea; one size will not fit all. Different combinations of approaches will be needed in different geographies based on local ecology and vector biology, malaria epidemiology and operational capacity. While the need for national malaria control programmes to record epidemiological indicators of impact is obvious, programmes should also measure simple but robust indicators of mosquito and human behaviours that create these intervention opportunities, so that the best options can be selected, optimised and combined.5 41 42

Emerging opportunities for financing more ambitious malaria vector control strategies in lower income settings

Ambitions to provide vertical mosquito population control services already have political support in some LMICs, to the extent that they finance them from predominantly domestic sources.9–11 Substantial international financing mechanisms already exist for improved housing, pharmaceutical supply and veterinary extension services in LMICs, all of which could be leveraged to support malaria vector control. Furthermore, a well-developed array of products with established high-value markets exist for personal protection, veterinary health and construction materials in HICs. Such commodities could be exploited to leverage subsidisation or donation for malaria control in LMICs, in the same way that curative drugs for several neglected tropical diseases of humans are procured.43 For example, donations of short-acting oral formulations of ivermectin are already used for eliminating onchocerciasis endoparasites from human populations, but longer lasting veterinary formulations for killing ectoparasites of livestock could also be used to suppress zoophagic populations of malaria vectors through agricultural extension systems that already exist in many LMICs.5 44 Similarly, construction of mosquito-proofed houses and vertically delivered mosquito control are both well-established industries in HICs, for which creative financing mechanisms to support application in LMICs could be created.

Conclusions

Malaria control is at an important historical juncture, as global progress over recent years is documented1 and attention turns to the 2030 elimination and 2040 eradication goals.3 4 Recognising the challenges facing malaria vector control, including residual transmission, insecticide resistance and operational constraints to LLINs and IRS effectiveness, the WHO has acknowledged the need to overhaul the portfolio of vector control options available to national malaria control programmes.19 Nevertheless, the term residual transmission was only formally defined in 2016,26 and the Global Technical Strategy for Malaria up to 20304 only mentions it in passing, without transparently acknowledging it as a fundamental, purely biological limitation to the level of impact that can be reasonably expected of LLINs or IRS.5 6 Global policy now needs to consistently and unambiguously realign with both the programmatic needs and biological realities of malaria vector control, to unambiguously prioritise accelerated development of the diverse options available for malaria vector control in LMICs.

At present, the evidence base relating to these additional vector control options is lacking both in quantity and quality with respect to their application to prevention of malaria and other mosquito-borne pathogens.45 46 Developing such an expanded toolbox for malaria vector control will require investment in product and system development, high-quality evaluations of efficacy and effectiveness, and operational research to define best practices for programmatic use of these additional interventions.

Acknowledgments

The authors thank Steve Torr, Greg Devine, Philip McCall, Peter DeChant, Silas Majambere, Nick Hamon, Nicole Achee, John Grieco, Chris Thomas, Zac Mtema and John Clayton for their invaluable advice, as well as Simon Sawadogo, Kyeba Swai, Lina Finda, John Masalu, Sheila Ogoma, Bart Knols and Eleanore Sternberg for providing us with prepublication access to their work. The authors also thank David Savory and Hugh Sturrock for kindly providing estimates of the world's at-risk population living at the two population density strata.

Footnotes

Handling editor: Seye Abimbola

Contributors: GFK, AT, LST and RDG conceived the study. GFK, AT, AD, CJC, JMM, FOO, SB, GN, YAW, DM, LST and RDG all contributed substantively to the literature identified and interpreted, and to the logic and presentation of the content. GFK acts as guarantor for the manuscript, which he drafted in consultation with the other authors. All authors critically reviewed and approved the final manuscript.

Funding: Financial support for this study was kindly provided by the European Union through the Seventh Framework Programme (FP7/2007-2013 grant agreement 265660) and the Parker Foundation through a gift to the Global Health Group Malaria Elimination Initiative at the University of California at San Francisco. Individual authors were also supported by the following personal awards: a Wellcome Trust Intermediate Research Fellowship (FOO: award number 102350/Z/13/Z), a Ramón Areces Foundation Fellowship (CJC) and a Skills Development Fellowship (LST: award number N011570) jointly funded by the UK Medical Research Council and the UK Department for International Development.

Competing interests: None declared.

Provenance and peer review: Not commissioned; externally peer reviewed.

Data sharing statement: No additional data are available.

References

  • 1.Bhatt S, Weiss DJ, Cameron E, et al. . The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 2015;526:207–11. 10.1038/nature15535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.WHO. World Malaria Report 2015. Geneva: World Health Organization, 2015:243. [Google Scholar]
  • 3.Gates W, Chambers R. Aspiration to action: what will it take to end malaria? 2015:60 http://endmalaria2040.org/assets/Aspiration-to-Action.pdf [Google Scholar]
  • 4.WHO. Global technical strategy for malaria for 2016–2030. Geneva: World Health Organization, Global Malaria Programme, 2015:32. [Google Scholar]
  • 5.Killeen GF. Characterizing, controlling and eliminating residual malaria transmission. Malar J 2014;13:330 10.1186/1475-2875-13-330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Killeen GF, Kiware SS, Okumu FO, et al. . Going beyond personal protection against mosquito bites to eliminate malaria transmission: population suppression of malaria vectors that exploit both human and animal blood. BMJ Global Health 2016;2:e000198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Challet GL. Mosquito abatement district programs in the United States. Gaoxiong Yi Xue Ke Xue Za Zhi 1994;10 Suppl:S67–73. [PubMed] [Google Scholar]
  • 8.Dale PE, Carlson DB, Easton CS. Four degrees of latitude: mosquito control on the “right” coasts of Australia and Florida, USA. J Am Mosq Control Assoc 2008;24:427–37. 10.2987/5680.1 [DOI] [PubMed] [Google Scholar]
  • 9.WHO. Larval source management-A supplementary measure for malaria vector control: an operational manual. Geneva: World Health Organization, 2013:116. [Google Scholar]
  • 10.Tusting LS, Thwing J, Sinclair D, et al. . Mosquito larval source management for controlling malaria. Cochrane Database Syst Rev 2013;(8):CD008923 10.1002/14651858.CD008923.pub2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Smith Gueye C, Newby G, Gosling RD, et al. . Strategies and approaches to vector control in nine malaria-eliminating countries: a cross-case study analysis. Malar J 2016;15:2 10.1186/s12936-015-1054-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hemingway J, Ranson H, Magill A, et al. . Averting a malaria disaster: will insecticide resistance derail malaria control? Lancet 2016;387:1785–8. 10.1016/S0140-6736(15)00417-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ranson H, Lissenden N. Insecticide resistance in African Anopheles mosquitoes: a worsening situation that needs urgent action to maintain malaria control. Trends Parasitol 2016;32:187–96. 10.1016/j.pt.2015.11.010 [DOI] [PubMed] [Google Scholar]
  • 14.WHO. Insecticide treated mosquito nets: a position statement. Geneva: Global Malaria Programme; World Health Organization, 2007:10. [Google Scholar]
  • 15.Killeen GF, Smith TA, Ferguson HM, et al. . Preventing childhood malaria in Africa by protecting adults from mosquitoes with insecticide-treated nets. PLoS Med 2007;4:e229 10.1371/journal.pmed.0040229 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Mnzava AP, Knox TB, Temu EA, et al. . Implementation of the global plan for insecticide resistance management in malaria vectors: progress, challenges and the way forward. Malar J 2015;14:173 10.1186/s12936-015-0693-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Oxborough R. Trends in US President's Malaria Initiative-funded indoor residual spray coverage and insecticide choice in sub-Saharan Africa (2008–2015): urgent need for affordable, long-lasting insecticides. Malar J 2016;15:146 10.1186/s12936-016-1201-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Chanda E, Mzilahowa T, Chipwanya J, et al. . Preventing malaria transmission by indoor residual spraying in Malawi: grappling with the challenge of uncertain sustainability. Malar J 2015;14:254 10.1186/s12936-015-0759-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.WHO. Guidance note—control of residual malaria parasite transmission. World Health Organization Global Malaria Programme, 2014:5. [Google Scholar]
  • 20.Mnyone LL, Lyimo IN, Lwetoijera DW, et al. . Exploiting the behaviour of wild malaria vectors to achieve high infection with fungal biocontrol agents. Malar J 2012;11:87 10.1186/1475-2875-11-87 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Sternberg ED, Ng'habi KR, Lyimo IN, et al. . Eave tubes for malaria control in Africa: initial development and semi-field evaluations in Tanzania. Malar J 2016;15:447 10.1186/s12936-016-1499-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Killeen GF, Masalu JP, Chinula D, et al. . Insecticide-treated combinations of window screens and eave baffles may help control physiologically and behaviorally resistant malaria vector mosquitoes. Emerg Infect Dis 2017;23:782–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.WHO. Global plan for insecticide resistance management in malaria vectors (GPIRM). Geneva: Global Malaria Control Programme, 2012:130. [Google Scholar]
  • 24.Farenhorst M, Mouatcho JC, Kikankie CK, et al. . Fungal infection counters insecticide resistance in African malaria mosquitoes. Proc Natl Acad Sci USA 2009;106:17443–7. 10.1073/pnas.0908530106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Bhatt S, Weiss DJ, Mappin B, et al. . Coverage and system efficiencies of insecticide-treated nets in Africa from 2000 to 2017. eLife 2015;4:e09672 10.7554/eLife.09672 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.WHO. WHO malaria terminology. 2016:31. [Google Scholar]
  • 27.Lwetoijera D, Harris C, Kiware S, et al. . Effective autodissemination of pyriproxyfen to breeding sites by the exophilic malaria vector Anopheles arabiensis in semi-field settings in Tanzania. Malar J 2014;13:161 10.1186/1475-2875-13-161 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Hammond A, Galizi R, Kyrou K, et al. . A CRISPR-Cas9 gene drive system targeting female reproduction in the malaria mosquito vector Anopheles gambiae. Nat Biotech 2016;34:78–83. 10.1038/nbt.3439 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Shaw WR, Marcenac P, Childs LM, et al. . Wolbachia infections in natural Anopheles populations affect egg laying and negatively correlate with Plasmodium development. Nature Comm 2016;7:11772 10.1038/ncomms11772 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Ouédraogo AL, Bastiaens GJ, Tiono AB, et al. . Efficacy and safety of the mosquitocidal drug ivermectin to prevent malaria transmission after treatment: a double-blind, randomized, clinical trial. Clin Infect Dis 2015;60:357–65. 10.1093/cid/ciu797 [DOI] [PubMed] [Google Scholar]
  • 31.Chaccour CJ, Kobylinski KC, Bassat Q, et al. . Ivermectin to reduce malaria transmission: a research agenda for a promising new tool for elimination. Malar J 2013;12:153 10.1186/1475-2875-12-153 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Kitron U, Spielman A. Suppression of transmission of malaria through source reduction: antianopheline measures applied in Israel, the United States, and Italy. Rev Infect Dis 1989;11:391–406. 10.1093/clinids/11.3.391 [DOI] [PubMed] [Google Scholar]
  • 33.Lindsay SW, Emerson PM, Charlwood JD. Reducing malaria by mosquito-proofing homes. Trends Parasitol 2002;18:510–14. 10.1016/S1471-4922(02)02382-6 [DOI] [PubMed] [Google Scholar]
  • 34.Chaki PP, Kannady K, Mtasiwa D, et al. . Institutional evolution of a community-based programme for malaria control through larval source management in Dar es Salaam, United Republic of Tanzania. Malar J 2014;13:245 10.1186/1475-2875-13-245 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Worrall E, Fillinger U. Large-scale use of mosquito larval source management for malaria control in Africa: a cost analysis. Malar J 2011;10:338 10.1186/1475-2875-10-338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Dambach P, Schleicher M, Stahl HC, et al. . Routine implementation costs of larviciding with Bacillus thuringiensis israelensis against malaria vectors in a district in rural Burkina Faso. Malar J 2016;15:380 10.1186/s12936-016-1438-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Rahman R, Lesser A, Mboera L, et al. . Cost of microbial larviciding for malaria control in rural Tanzania. Trop Med Int Health 2016;21:1468–75. 10.1111/tmi.12767 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Fillinger U, Ndenga B, Githeko A, et al. . Integrated malaria vector control with microbial larvicides and insecticide-treated nets in western Kenya: a controlled trial. Bull World Health Organ 2009;87:655–65. 10.2471/BLT.08.055632 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Sawadogo SP, Niang A, Bilgo E, et al. . Targeting male mosquito swarms to control malaria vector density. PLoS ONE 2017;12:e0173273 10.1371/journal.pone.0173273 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Ferguson HM, Dornhaus A, Beeche A, et al. . Ecology: a prerequisite for malaria elimination and eradication. PLoS Med 2010;7:e1000303 10.1371/journal.pmed.1000303 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Killeen GF, Seyoum A, Gimnig JE, et al. . Made-to-measure malaria vector control strategies: rational design based on insecticide properties and coverage of blood resources for mosquitoes. Malar J 2014;13:146 10.1186/1475-2875-13-146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Killeen GF, Marshall JM, Kiware SS, et al. . Measuring, manipulating and exploiting behaviours of adult mosquitoes to optimize malaria vector control impact. BMJ Global Health 2016;2:e000212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Colatrella B. The Mectizan Donation Program: 20 years of successful collaboration—a retrospective. Ann Trop Med Parasitol 2008;102(Suppl 1):7–11. 10.1179/136485908X337418 [DOI] [PubMed] [Google Scholar]
  • 44.Chaccour C, Killeen GF. Mind the gap: residual malaria transmission, veterinary endectocides and livestock as targets for malaria vector control. Malar J 2016;15:24 10.1186/s12936-015-1063-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wilson AL, Boelaert M, Kleinschmidt I, et al. . Evidence-based vector control? Improving the quality of vector control trials. Trends Parasitol 2015;31:380–90. 10.1016/j.pt.2015.04.015 [DOI] [PubMed] [Google Scholar]
  • 46.Bowman LR, Donegan S, McCall PJ. Is dengue vector control deficient in effectiveness or evidence? A systematic review and meta-analysis. PLoS Negl Trop Dis 2016;10:e0004551 10.1371/journal.pntd.0004551 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Bonds JA. Ultra-low-volume space sprays in mosquito control: a critical review. Med Vet Entomol 2012;26:121–30. 10.1111/j.1365-2915.2011.00992.x [DOI] [PubMed] [Google Scholar]
  • 48.Itoh T, Marijani JH, Keto AJ, et al. . Control of Anopheles mosquitoes by ultra-low volume applications of d-allethrin and d-phenothrin in combination with larvicidings of fenitrothion in Tanzania. J Am Mosq Control Assoc 1988;4:563–4. [PubMed] [Google Scholar]
  • 49.Hobbs JH. A trial of ultra-low volume pyrethrin spraying as a malaria control measure in El Salvador. Mosquito News 1976;36:132–7. [Google Scholar]
  • 50.Roll Back Malaria Vector Control Working Group. Consensus statement on housing and malaria. Geneva: Roll Back Malaria Partnership-United Nations Development Program-United Nations Habitat, 2015:7. [Google Scholar]
  • 51.Ogoma SB, Kannady K, Sikulu M, et al. . Window screening, ceilings and closed eaves as sustainable ways to control malaria in Dar es Salaam, Tanzania. Malar J 2009;8:221 10.1186/1475-2875-8-221 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Swai JK, Finda MF, Madumla EP, et al. . Studies on mosquito biting risk among migratory rice farmers in rural south-eastern Tanzania and development of a portable mosquito-proof hut. Malar J 2016;15:564 10.1186/s12936-016-1616-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Tungu PK, Malima R, Mosha FW, et al. . Evaluation of Icon Maxx, a long-lasting treatment kit for mosquito nets: experimental hut trials against anopheline mosquitoes in Tanzania. Malar J 2015;14:225 10.1186/s12936-015-0742-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Andriessen R, Snetselaar J, Suer RA, et al. . Electrostatic coating enhances bioavailability of insecticides and breaks pyrethroid resistance in mosquitoes. Proc Natl Acad Sci USA 2015;112:12081–6. 10.1073/pnas.1510801112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Diabaté A, Bilgo E, Dabiré RK, et al. . Environmentally friendly tool to control mosquito populations without risk of insecticide resistance: the Lehmann's funnel entry trap. Malar J 2013;12:196 10.1186/1475-2875-12-196 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Macintyre K, Sosler S, Letipila F, et al. . A new tool for malaria prevention? Results of a trial of permethrin-impregnated bedsheets (shukas) in an area of unstable transmission. Int J Epidemiol 2003;32:157–60. [DOI] [PubMed] [Google Scholar]
  • 57.Kitau J, Oxborough R, Kaye A, et al. . Laboratory and experimental hut evaluation of a long-lasting insecticide treated blanket for protection against mosquitoes. Parasit Vectors 2014;7:129 10.1186/1756-3305-7-129 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Deressa W, Yihdego YY, Kebede Z, et al. . Effect of combining mosquito repellent and insecticide treated net on malaria prevalence in Southern Ethiopia: a cluster-randomised trial. Parasit Vectors 2014;7:132 10.1186/1756-3305-7-132 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Sluydts V, Durnez L, Heng S, et al. . Efficacy of topical mosquito repellent (picaridin) plus long-lasting insecticidal nets versus long-lasting insecticidal nets alone for control of malaria: a cluster randomised controlled trial. Lancet Infect Dis 2016;16:1169–77. 10.1016/S1473-3099(16)30148-7 [DOI] [PubMed] [Google Scholar]
  • 60.Grieco JP, Achee NL, Chareonviriyaphap T, et al. . A new classification system for the actions of IRS chemicals traditionally used for malaria control. PLoS ONE 2007;2:e716 10.1371/journal.pone.0000716 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Moore SJ, Davies C, Cameron MM. Are mosquitoes diverted from repellent-using individuals to non-users? Results of a field study in Bolivia. Trop Med Int Health 2007;12:532–9. 10.1111/j.1365-3156.2006.01811.x [DOI] [PubMed] [Google Scholar]
  • 62.Maia MF, Onyango SP, Thele M, et al. . Do topical repellents divert mosquitoes within a community? Health equity implications of topical repellents as a mosquito bite prevention tool. PLoS ONE 2013;8:e84875 10.1371/journal.pone.0084875 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Killeen GF, Moore SJ. Target product profiles for protecting against outdoor malaria transmission. Malar J 2012;11:17 10.1186/1475-2875-11-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Achee NL, Bangs MJ, Farlow R, et al. . Spatial repellents: from discovery and development to evidence-based validation. Malar J 2012;11:164 10.1186/1475-2875-11-164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Ogoma SB, Ngonyani H, Simfukwe ET, et al. . The mode of action of spatial repellents and their impact on vectorial capacity of Anopheles gambiae sensu stricto. PLoS ONE 2014;9:e110433 10.1371/journal.pone.0110433 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Govella NJ, Ogoma SB, Paliga J, et al. . Impregnating hessian strips with the volatile pyrethroid transfluthrin prevents outdoor exposure to vectors of malaria and lymphatic filariasis in urban Dar es Salaam, Tanzania. Parasit Vectors 2015;8:322 10.1186/s13071-015-0937-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Ogoma SB, Mmando AS, Swai JK, et al. . A low technology emanator treated with the volatile pyrethroid transfluthrin confers long term protection against outdoor biting vectors of lymphatic filariasis, arboviruses and malaria. PLoS Negl Trop Dis 2017;11:e0005455 10.1371/journal.pntd.0005455 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Masalu JP, Finda M, Okumu FO, et al. . Efficacy and user acceptability of transfluthrin-treated sisal and hessian decorations for protecting against mosquito bites in outdoor bars. Parasit Vectors 2016; in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.WHO. Guidelines for efficacy testing of spatial repellents. Geneva: World Health Organization, 2013. [Google Scholar]
  • 70.Horstmann S, Sonneck R, Velten R, et al. . United States of America patent US 2015/0289513 A1. 15 Oct 2015. [Google Scholar]
  • 71.Homan T, Hiscox A, Mweresa CK, et al. . The effect of mass mosquito trapping on malaria transmission and disease burden (SolarMal): a stepped-wedge cluster-randomised trial. Lancet 2016;388:1193–201. 10.1016/S0140-6736(16)30445-7 [DOI] [PubMed] [Google Scholar]
  • 72.Killeen GF. Mass trapping of malaria vector mosquitoes. Lancet 2016;388:1136–7. 10.1016/S0140-6736(16)30674-2 [DOI] [PubMed] [Google Scholar]
  • 73.Garrett-Jones C, Boreham P, Pant CP. Feeding habits of anophelines (Diptera: Culicidae) in 1971-78, with reference to the human blood index: a review. Bull Entomol Res 1980;70:165–85. 10.1017/S0007485300007422 [DOI] [Google Scholar]
  • 74.Butters MP, Kobylinski KC, Deus KM, et al. . Comparative evaluation of systemic drugs for their effects against Anopheles gambiae. Acta Trop 2012;121:34–43. 10.1016/j.actatropica.2011.10.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Rowland M, Durrani N, Kenward M, et al. . Control of malaria in Pakistan by applying deltamethrin insecticide to cattle: a community-randomised trial. Lancet 2001;357:1837–41. 10.1016/S0140-6736(00)04955-2 [DOI] [PubMed] [Google Scholar]
  • 76.Killeen GF, Kiware SS, Seyoum A, et al. . Comparative assessment of diverse strategies for malaria vector population control based on measured rates at which mosquitoes utilize targeted resource subsets. Malar J 2014;13:338 10.1186/1475-2875-13-338 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Bardosh K, Waiswa C, Welburn SC. Conflict of interest: use of pyrethroids and amidines against tsetse and ticks in zoonotic sleeping sickness endemic areas of Uganda. Parasit Vectors 2013;6:204 10.1186/1756-3305-6-204 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Qualls WA, Müller GC, Traore SF, et al. . Indoor use of attractive toxic sugar bait (ATSB) to effectively control malaria vectors in Mali, West Africa. Malar J 2015;14:301 10.1186/s12936-015-0819-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Junnila A, Revay EE, Müller GC, et al. . Efficacy of attractive toxic sugar baits (ATSB) against Aedes albopictus with garlic oil encapsulated in beta-cyclodextrin as the active ingredient. Acta Trop 2015;152:195–200. 10.1016/j.actatropica.2015.09.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Revay EE, Schlein Y, Tsabari O, et al. . Formulation of attractive toxic sugar bait (ATSB) with safe EPA-exempt substance significantly diminishes the Anopheles sergentii population in a desert oasis. Acta Trop 2015;150:29–34. 10.1016/j.actatropica.2015.06.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Diabate A, Tripet F. Targeting male mosquito mating behaviour for malaria control. Parasit Vectors 2015;8:347 10.1186/s13071-015-0961-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Nájera JA. Malaria control: achievements, problems and strategies. Parassitologia 2001;43:1–89. [PubMed] [Google Scholar]
  • 83.Hougard JM, Yaméogo L, Sékétéli A, et al. . Twenty-two years of blackfly control in the onchocerciasis control programme in West Africa. Parasitol Today (Regul Ed) 1997;13:425–31. 10.1016/S0169-4758(97)01145-9 [DOI] [PubMed] [Google Scholar]
  • 84.Dias JC, Silveira AC, Schofield CJ. The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 2002;97:603–12. [Published Online First: 2002/09/10]. 10.1590/S0074-02762002000500002 [DOI] [PubMed] [Google Scholar]
  • 85.Torr SJ, Hargrove JW, Vale GA. Towards a rational policy for dealing with tsetse. Trends Parasitol 2005;21:537–41. 10.1016/j.pt.2005.08.021 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Global Health are provided here courtesy of BMJ Publishing Group

RESOURCES